{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T11:19:17Z","timestamp":1788347957357,"version":"build-2803163510"},"reference-count":81,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Glioblastoma (GBM) is the most aggressive type of primary brain tumour in adults, and after treatment, it is also difficult to know whether a person\u2019s health has improved. Pseudoprogression (PsP), particularly following radiotherapy and combination therapy with temozolomide and new immunotherapies, may be falsely identified as true progression (TP) by conventional MRI, thus leading to premature termination of treatment or unnecessary intensification of therapy. Although RANO, iRANO and RANO 2.0 have improved the assessment of response, structural MRI alone is unable to reveal the biological complexity of the tumour microenvironment. Artificial Intelligence (AI)-based radiomics and radiogenomics aid in the characterisation of GBM. Several Magnetic Resonance Imaging (MRI) sequences are used to obtain quantitative data, such as the conventional T1-weighted images, diffusion-weighted images, perfusion-weighted images and others, to acquire information on cell density, blood vessel distribution, immune cell concentration, molecular modifications and the effect of therapy. Combine imaging characteristics with liquid biopsy, genomic data and patient health records to enhance the accuracy of diagnosis and discover high-sensitivity surrogate markers for immune checkpoint inhibitor and CAR-T cell therapy clinical trials. Clinical translation still faces numerous limitations such as inconsistent research protocols, small study cohorts, insufficient external validation, inadequate model interpretability and inconsistent reference standards. In the future, many research groups will conduct multi-centre validation, standardize workflows, open-source reporting and release clinically interpretable models. The above ways can reduce the bias induced by PsP and improve differentiation between pseudoprogression and true progression to facilitate prompt treatment for most people.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1920605","type":"journal-article","created":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T11:07:45Z","timestamp":1788347265000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["AI-driven radiomics and radiogenomics: supporting the assessment and differentiation of pseudoprogression in cellular immunotherapy for glioblastoma"],"prefix":"10.3389","volume":"17","author":[{"given":"Yihua","family":"Han","sequence":"first","affiliation":[{"name":"Department of Neurology, Affiliated Hospital of Yanbian University (Yanbian University Hospital)","place":["Yanji, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Anaesthesiology, Affiliated Hospital of Yanbian University (Yanbian University Hospital)","place":["Yanji, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanji","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of Neurology, Affiliated Hospital of Yanbian University (Yanbian University Hospital)","place":["Yanji, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songbiao","family":"Cui","sequence":"additional","affiliation":[{"name":"Department of Neurology, Affiliated Hospital of Yanbian University (Yanbian University Hospital)","place":["Yanji, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanghui","family":"Dong","sequence":"additional","affiliation":[{"name":"Department of Neurology, Affiliated Hospital of Yanbian University (Yanbian University Hospital)","place":["Yanji, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2022.2844","article-title":"World Health Organization 2021 classification of central nervous system tumors and implications for therapy for adult-type gliomas: A review","volume":"8","author":"Berger","year":"2022","journal-title":"JAMA Oncol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1186\/s12967-026-08226-7","article-title":"Deciphering the glioblastoma microenvironmental landscape with multi-modal radiogenomics to guide prognosis and personalized therapy","volume":"24","author":"Zhao","year":"2026","journal-title":"J Transl Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.3390\/biomedicines13092136","article-title":"Radiotherapy in glioblastoma multiforme: Evolution, limitations, and molecularly guided future","volume":"13","author":"Fern\u00e1ndez","year":"2025","journal-title":"Biomedicines"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105780","article-title":"Glioblastoma multiforme (gbm): An overview of current therapies and mechanisms of resistance","volume":"171","author":"Wu","year":"2021","journal-title":"Pharmacol Res"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1691562","article-title":"Car t-cell therapy induced pseudoprogression","volume":"17","author":"Dean","year":"2026","journal-title":"Front Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1610497","article-title":"Regression of glioblastoma after chimeric antigen receptor t-cell therapy","volume":"375","author":"Brown","year":"2016","journal-title":"N Engl J Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.3390\/cells13181567","article-title":"Prospective molecular targets for natural killer cell immunotherapy against glioblastoma multiforme","volume":"13","author":"Cooksey","year":"2024","journal-title":"Cells"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1093\/noajnl\/vdaf232","article-title":"Limited evidence of pseudoprogression following immune checkpoint inhibitor (ici) therapy in glioblastoma","volume":"8","author":"Rhee","year":"2026","journal-title":"Neuro-Oncology Adv"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.2463\/mrms.rev.2015-0053","article-title":"Recent application of advanced mr imaging to predict pseudoprogression in high-grade glioma patients","volume":"15","author":"Yoo","year":"2016","journal-title":"Magnetic Resonance Med Sci MRMS Off J Japan Soc Magnetic Resonance Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1177\/10732748251322072","article-title":"Evaluating immunotherapy responses in neuro-oncology for glioblastoma and brain metastases: A brief review featuring three cases","volume":"32","author":"Kertmen","year":"2025","journal-title":"Cancer Control J Moffitt Cancer Center"},{"key":"B11","doi-asserted-by":"publisher","first-page":"795","DOI":"10.3390\/diagnostics13040795","article-title":"Timing of early postoperative mri following primary glioblastoma surgery-a retrospective study of contrast enhancements in 311 patients","volume":"13","author":"Rykkje","year":"2023","journal-title":"Diagnostics (Basel Switzerland)"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s00234-026-03983-0","article-title":"Radiomics-based artificial intelligence models in brain tumors: A systematic review and meta-analysis of diagnostic performance","volume":"68","author":"Reyes","year":"2026","journal-title":"Neuroradiology"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noy032","article-title":"Car t-cell therapy for glioblastoma: Recent clinical advances and future challenges","volume":"20","author":"Bagley","year":"2018","journal-title":"Neuro-Oncology"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.790674","article-title":"Advanced imaging techniques for differentiating pseudoprogression and tumor recurrence after immunotherapy for glioblastoma","volume":"12","author":"Li","year":"2021","journal-title":"Front Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s10456-026-10031-1","article-title":"Vascular normalization by erianin unleashes car-t immunotherapy in glioblastoma","volume":"29","author":"Zhou","year":"2026","journal-title":"Angiogenesis"},{"key":"B16","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s43018-020-00147-8","article-title":"Targeting pak4 to reprogram the vascular microenvironment and improve car-t immunotherapy for glioblastoma","volume":"2","author":"Ma","year":"2021","journal-title":"Nat Cancer"},{"key":"B17","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s11060-026-05497-4","article-title":"Endogenous immune recruitment in glioblastoma car t therapy: Cytokine, myeloid, and chemokine circuitry","volume":"177","author":"Liu","year":"2026","journal-title":"J Neuro-Oncol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adj4678","article-title":"An immunosuppressive vascular niche drives macrophage polarization and immunotherapy resistance in glioblastoma","volume":"10","author":"Yang","year":"2024","journal-title":"Sci Adv"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2022.04.010","article-title":"Mechanism and therapeutic potential of tumor-immune symbiosis in glioblastoma","volume":"8","author":"Pang","year":"2022","journal-title":"Trends Cancer"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/cti2.1519","article-title":"Endogenous bystander killing mechanisms enhance the activity of novel fap-specific car-t cells against glioblastoma","volume":"13","author":"Yu","year":"2024","journal-title":"Clin Trans Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2023.103353","article-title":"Mri histogram analysis of tumor-infiltrating cd8+ t cell levels in patients with glioblastoma","volume":"37","author":"Xue","year":"2023","journal-title":"NeuroImage Clin"},{"key":"B22","doi-asserted-by":"publisher","first-page":"4429","DOI":"10.3390\/cancers15184429","article-title":"Radiomics: The new promise for differentiating progression, recurrence, pseudoprogression, and radionecrosis in glioma and glioblastoma multiforme","volume":"15","author":"Alizadeh","year":"2023","journal-title":"Cancers"},{"key":"B23","doi-asserted-by":"publisher","first-page":"10985","DOI":"10.1038\/s41598-024-61925-3","article-title":"Prognostic relevance of radiological findings on early postoperative mri for 187 consecutive glioblastoma patients receiving standard therapy","volume":"14","author":"Rykkje","year":"2024","journal-title":"Sci Rep"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1200\/jco.22.01862","article-title":"Intraoperative mri-guided resection is not superior to 5-aminolevulinic acid guidance in newly diagnosed glioblastoma: A prospective controlled multicenter clinical trial","volume":"41","author":"Roder","year":"2023","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1093\/neuros\/nyz398","article-title":"Frequency and evolution of new postoperative enhancement on 3 tesla intraoperative and early postoperative magnetic resonance imaging","volume":"87","author":"Miskin","year":"2020","journal-title":"Neurosurgery"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1227\/neu.0000000000004012","article-title":"Impact of postoperative diffuse-weighted imaging rim restriction on neurological outcomes after resection of newly diagnosed isocitrate dehydrogenase-wildtype glioblastoma","author":"Menna","year":"2026","journal-title":"Neurosurgery"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2009.26.3541","article-title":"Updated response assessment criteria for high-grade gliomas: Response assessment in neuro-oncology working group","volume":"28","author":"Wen","year":"2010","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/690585","article-title":"Early pseudoprogression following chemoradiotherapy in glioblastoma patients: The value of rano evaluation","volume":"2013","author":"Linhares","year":"2013","journal-title":"J Oncol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1093\/nop\/npw021","article-title":"Evaluation of pseudoprogression in patients with glioblastoma","volume":"4","author":"Kucharczyk","year":"2017","journal-title":"Neuro-Oncology Pract"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/not328","article-title":"Evaluation of pseudoprogression in patients with glioblastoma multiforme using dynamic magnetic resonance imaging with ferumoxytol calls rano criteria into question","volume":"16","author":"Nasseri","year":"2014","journal-title":"Neuro-Oncology"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.Ccr-15-1334","article-title":"Late pseudoprogression in glioblastoma: Diagnostic value of dynamic o-(2-[18f]fluoroethyl)-l-tyrosine pet","volume":"22","author":"Kebir","year":"2016","journal-title":"Clin Cancer Res Off J Am Assoc For Cancer Res"},{"key":"B32","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1186\/s12885-021-08414-2","article-title":"Refinement of response assessment in neuro-oncology (rano) using non-enhancing lesion type and contrast enhancement evolution pattern in idh wild-type glioblastomas","volume":"21","author":"Moon","year":"2021","journal-title":"BMC Cancer"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.679331","article-title":"A comparative retrospective study of immunotherapy rano versus standard rano criteria in glioblastoma patients receiving immune checkpoint inhibitor therapy","volume":"11","author":"Chen","year":"2021","journal-title":"Front Oncol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.Ccr-23-0009","article-title":"Taming glioblastoma in \"real time\": Integrating multimodal advanced neuroimaging\/ai tools towards creating a robust and therapy agnostic model for response assessment in neuro-oncology","volume":"29","author":"de Godoy","year":"2023","journal-title":"Clin Cancer Res Off J Am Assoc For Cancer Res"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(15)00088-1","article-title":"Immunotherapy response assessment in neuro-oncology: A report of the rano working group","volume":"16","author":"Okada","year":"2015","journal-title":"Lancet Oncol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1200\/jco.23.01059","article-title":"Rano 2.0: Update to the response assessment in neuro-oncology criteria for high- and low-grade gliomas in adults","volume":"41","author":"Wen","year":"2023","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/1696387","article-title":"Role of dynamic susceptibility contrast perfusion mri in glioma progression evaluation","volume":"2021","author":"Quan","year":"2021","journal-title":"J Oncol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.5114\/pjr.2023.132168","article-title":"Radiomics in the diagnosis of glioblastoma","volume":"88","author":"Kwiatkowska-Miernik","year":"2023","journal-title":"Polish J Radiol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/s41698-023-00413-9","article-title":"Radiomics for characterization of the glioma immune microenvironment","volume":"7","author":"Khalili","year":"2023","journal-title":"NPJ Precis Oncol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"27","DOI":"10.31661\/jbpe.v0i0.2208-1525","article-title":"Simplifying radiomics workflow for predicting grade of glioma: An approach for rapid and reproducible radiomics","volume":"15","author":"Soleymani","year":"2025","journal-title":"J Biomed Phys Eng"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.acra.2025.06.047","article-title":"Precision diagnosis and treatment monitoring of glioma via pet radiomics","volume":"32","author":"Zhou","year":"2025","journal-title":"Acad Radiol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-023-10034-2","article-title":"Impact of signal intensity normalization of mri on the generalizability of radiomic-based prediction of molecular glioma subtypes","volume":"34","author":"Foltyn-Dumitru","year":"2024","journal-title":"Eur Radio"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.3390\/cancers14061475","article-title":"Efficient radiomics-based classification of multi-parametric mr images to identify volumetric habitats and signatures in glioblastoma: A machine learning approach","volume":"14","author":"Chiu","year":"2022","journal-title":"Cancers"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymeth.2020.06.003","article-title":"Radiomics in neuro-oncology: Basics, workflow, and applications","volume":"188","author":"Lohmann","year":"2021","journal-title":"Methods (San Diego Calif)"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3348\/kjr.2019.0847","article-title":"Radiomics and deep learning from research to clinical workflow: Neuro-oncologic imaging","volume":"21","author":"Park","year":"2020","journal-title":"Korean J Radiol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s40644-024-00682-y","article-title":"Artificial intelligence-based mri radiomics and radiogenomics in glioma","volume":"24","author":"Fan","year":"2024","journal-title":"Cancer Imaging Off Publ Int Cancer Imaging Soc"},{"key":"B47","doi-asserted-by":"publisher","first-page":"2568","DOI":"10.3390\/cancers13112568","article-title":"Radiomic based machine learning performance for a three class problem in neuro-oncology: Time to test the waters","volume":"13","author":"Priya","year":"2021","journal-title":"Cancers"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1109\/tcbb.2020.3033538","article-title":"Prediction of glioma grade using intratumoral and peritumoral radiomic features from multiparametric mri images","volume":"19","author":"Cheng","year":"2022","journal-title":"IEEE\/ACM Trans Comput Biol Bioinf"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.crad.2021.03.019","article-title":"Machine learning-based radiomic evaluation of treatment response prediction in glioblastoma","volume":"76","author":"Patel","year":"2021","journal-title":"Clin Radiol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1093\/noajnl\/vdae159","article-title":"Distinction of pseudoprogression from true progression in glioblastomas using machine learning based on multiparametric magnetic resonance imaging and o(6)-methylguanine-methyltransferase promoter methylation status","volume":"6","author":"Yadav","year":"2024","journal-title":"Neuro-Oncology Adv"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.adro.2022.100916","article-title":"Radiomic analysis to predict histopathologically confirmed pseudoprogression in glioblastoma patients","volume":"8","author":"McKenney","year":"2023","journal-title":"Adv Radiat Oncol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.wneu.2024.01.074","article-title":"Glioblastoma pseudoprogression discrimination using multiparametric magnetic resonance imaging, principal component analysis, and supervised and unsupervised machine learning","volume":"183","author":"Thenier-Villa","year":"2024","journal-title":"World Neurosurg"},{"key":"B53","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12880-020-00545-5","article-title":"Differentiation of pseudoprogression from true progressionin glioblastoma patients after standard treatment: A machine learning strategy combinedwith radiomics features from T(1)-weighted contrast-enhanced imaging","volume":"21","author":"Sun","year":"2021","journal-title":"BMC Med Imaging"},{"key":"B54","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1038\/s41598-021-82467-y","article-title":"Differentiation of recurrent glioblastoma from radiation necrosis using diffusion radiomics with machine learning model development and external validation","volume":"11","author":"Park","year":"2021","journal-title":"Sci Rep"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-020-07414-3","article-title":"Diffusion and perfusion mri radiomics obtained from deep learning segmentation provides reproducible and comparable diagnostic model to human in post-treatment glioblastoma","volume":"31","author":"Park","year":"2021","journal-title":"Eur Radio"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.32790","article-title":"Histopathology-validated machine learning radiographic biomarker for noninvasive discrimination between true progression and pseudo-progression in glioblastoma","volume":"126","author":"Akbari","year":"2020","journal-title":"Cancer"},{"key":"B57","doi-asserted-by":"publisher","first-page":"3170","DOI":"10.1038\/s41467-019-11007-0","article-title":"Multicenter study demonstrates radiomic features derived from magnetic resonance perfusion images identify pseudoprogression in glioblastoma","volume":"10","author":"Elshafeey","year":"2019","journal-title":"Nat Commun"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0176528","article-title":"Analysis of heterogeneity in T2-weighted mr images can differentiate pseudoprogression from progression in glioblastoma","volume":"12","author":"Booth","year":"2017","journal-title":"PloS One"},{"key":"B59","doi-asserted-by":"publisher","first-page":"2706","DOI":"10.3390\/cancers12092706","article-title":"Machine learning model to predict pseudoprogression versus progression in glioblastoma using mri: A multi-institutional study (Krog 18-07)","volume":"12","author":"Jang","year":"2020","journal-title":"Cancers"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.3390\/cancers17121974","article-title":"Mri-based radiomics ensemble model for predicting radiation necrosis in brain metastasis patients treated with stereotactic radiosurgery and immunotherapy","volume":"17","author":"Chen","year":"2025","journal-title":"Cancers"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.displa.2024.102742","article-title":"Post-operative mri synthesis from pre-operative mri and post-operative ct using conditional gan for the assessment of degree of resection","volume":"83","author":"Miao","year":"2024","journal-title":"Displays"},{"key":"B62","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s10143-025-03718-4","article-title":"Artificial intelligence algorithms for differentiating pseudoprogression from true progression in high-grade gliomas: A systematic review and meta-analysis","volume":"48","author":"Palavani","year":"2025","journal-title":"Neurosurgical Rev"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1089\/cmb.2024.0518","article-title":"Cfinet: Cross-modality mri feature interaction network for pseudoprogression prediction of glioblastoma","volume":"32","author":"Lv","year":"2025","journal-title":"J Comput Biol A J Comput Mol Cell Biol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2025.111111","article-title":"A deep learning model for distinguishing pseudoprogression and tumor progression in glioblastoma based on pre- and post-operative contrast-enhanced T1 imaging","volume":"212","author":"Li","year":"2025","journal-title":"Radiotherapy Oncol J Eur Soc For Ther Radiol Oncol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"17133","DOI":"10.1038\/s41598-025-02026-7","article-title":"A self-supervised multimodal deep learning approach to differentiate post-radiotherapy progression from pseudoprogression in glioblastoma","volume":"15","author":"Gomaa","year":"2025","journal-title":"Sci Rep"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1002\/mp.14003","article-title":"Dc-Al Gan: Pseudoprogression and true tumor progression of glioblastoma multiform image classification based on dcgan and alexnet","volume":"47","author":"Li","year":"2020","journal-title":"Med Phys"},{"key":"B67","doi-asserted-by":"publisher","first-page":"12516","DOI":"10.1038\/s41598-018-31007-2","article-title":"Prediction of pseudoprogression versus progression using machine learning algorithm in glioblastoma","volume":"8","author":"Jang","year":"2018","journal-title":"Sci Rep"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-022-04080-x","article-title":"A deep learning model for discriminating true progression from pseudoprogression in glioblastoma patients","volume":"159","author":"Moassefi","year":"2022","journal-title":"J Neuro-Oncol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3390\/cancers18010036","article-title":"Timepoint-specific benchmarking of deep learning models for glioblastoma follow-up mri","volume":"18","author":"Guo","year":"2025","journal-title":"Cancers"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1093\/noajnl\/vdae055","article-title":"Radiogenomic biomarkers for immunotherapy in glioblastoma: A systematic review of magnetic resonance imaging studies","volume":"6","author":"Ghimire","year":"2024","journal-title":"Neuro-Oncology Adv"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A8225","article-title":"Molecular gbm versus histopathological gbm: Radiology-pathology-genetic correlation and the new who 2021 definition of glioblastoma","volume":"45","author":"Agarwal","year":"2024","journal-title":"AJNR Am J Neuroradiology"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.70304","article-title":"Development of a prediction model for progression risk in high-grade gliomas based on habitat radiomics and pathomics","volume":"13","author":"Zhu","year":"2026","journal-title":"Ann Clin Transl Neurol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1681966","article-title":"Shaping the glioblastoma microenvironment to enhance car-nk immunotherapy","volume":"16","author":"Tang","year":"2025","journal-title":"Front Immunol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12974-023-02749-2","article-title":"(18)F]F-ded pet imaging of reactive astrogliosis in neurodegenerative diseases: Preclinical proof of concept and first-in-human data","volume":"20","author":"Ballweg","year":"2023","journal-title":"J Neuroinflamm"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1186\/s40644-026-01018-8","article-title":"Radiomics-based differentiation between glioblastoma and primary central nervous system lymphoma: Ct vs mri","volume":"26","author":"Yu","year":"2026","journal-title":"Cancer Imaging Off Publ Int Cancer Imaging Soc"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A8280","article-title":"Impact of susan denoising and combat harmonization on machine learning model performance for Malignant brain neoplasms","volume":"45","author":"Bathla","year":"2024","journal-title":"AJNR Am J Neuroradiology"},{"key":"B77","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s13244-025-01950-6","article-title":"The clinical implications and interpretability of computational medical imaging (radiomics) in brain tumors","volume":"16","author":"Wang","year":"2025","journal-title":"Insights into Imaging"},{"key":"B78","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s41747-025-00652-4","article-title":"Non-invasive identification of mesenchymal glioblastoma using quantitative radiomic features from advanced diffusion mri: A preclinical-to-clinical transfer learning strategy","volume":"9","author":"Gallotti","year":"2025","journal-title":"Eur Radio Exp"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/j.acra.2025.05.016","article-title":"Interpretable machine learning models for differentiating glioblastoma from solitary brain metastasis using radiomics","volume":"32","author":"Xia","year":"2025","journal-title":"Acad Radiol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"20331","DOI":"10.1038\/s41598-020-77389-0","article-title":"Discriminating pseudoprogression and true progression in diffuse infiltrating glioma using multi-parametric mri data through deep learning","volume":"10","author":"Lee","year":"2020","journal-title":"Sci Rep"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-025-03745-0","article-title":"Intracerebroventricular bivalent car t cells targeting egfr and il-13r\u03b12 in recurrent glioblastoma: A phase 1 trial","volume":"31","author":"Bagley","year":"2025","journal-title":"Nat Med"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1920605\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T11:07:47Z","timestamp":1788347267000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1920605\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,2]]},"references-count":81,"alternative-id":["10.3389\/fimmu.2026.1920605"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1920605","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,2]]},"article-number":"1920605"}}